Record ID 32003000625
The UHC Drug Monographs are a continuing series of authoritative, concise evaluations of new and emerging pharmaceuticals. Monographs are written by drug information specialists and pharmacotherapists at institutions affiliated with UHC, and UHC coordinates their creation and edits them. In general, the focus is on drugs or classes of drugs that can be expected to significantly affect patient care or hospital finances. Therapeutic class reviews compare and contrast drugs within a pharmacologic class to evaluate their relative advantages, and they address issues concerning therapeutic interchange. Each monograph includes comprehensive information from the primary literature and provides recommendations for appropriate use.
Project Status: Completed
URL for project: http://www.uhc.edu/
Year Published: 2000
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: United States
- Antirheumatic Agents
- Tumor Necrosis Factor-alpha
Organisation Name: University HealthSystem Consortium
Contact Address: University HealthSystem Consortium, 2001 Spring Rd., Suite 700, Oak Brook, IL 60523 USA. Tel: 630-954-1700, Fax: 630/954-4730
Contact Name: email@example.com
Contact Email: firstname.lastname@example.org
Copyright: University HealthSystem Consortium
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.